Stock Rating - Female Health dividend per share is payable February 6, 2013 : The Female Health Company (NASDAQ-CM: FHCO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.06 per share. The dividend is payable February 6, 2013 to stockholders of record as of January 30, 2013. In January 2010, the Company announced the initiation of a cash dividend program and has subsequently paid twelve consecutive quarterly dividends. This represents a $0.24 annualized dividend and a dividend yield of 3.28%.
On a related note, analysts at Zacks upgraded shares of The Female Health from a “neutral” rating to an “outperform” rating in a research note to investors on Monday, December 17th. They now have a $7.70 price target on the stock.
The Female Health (FHCO) traded down 2.46% on Thursday, hitting $7.14. The stock’s 50-day moving average is currently $0.. The company has a market cap of $204.7 million and a price-to-earnings ratio of 13.81.
The Board of Directors also extended the Company’s stock repurchase program through December 31, 2013. The program was previously due to expire at the end of calendar year 2012 and has a repurchase cap of 3 million shares of common stock. The Company has repurchased approximately two million shares under the program, and approximately one million shares remain for potential repurchase
About Female Health Company (FHC)
The Female Health Company (FHC) manufactures, markets and sells the FC2 female condom. FC2 is approved by the United States Food and Drug Administration (FDA) that provides dual protection against unintended pregnancy and sexually transmitted infections (STIs), including Human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS).